Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese patent medicine for treating breast diseases and preparation method thereof

A technology of breast disease and Chinese patent medicine, which is applied in the field of Chinese patent medicine for treating breast disease and its preparation, to achieve the effect of quick effect, convenient use and low energy consumption

Active Publication Date: 2017-09-29
HEILONGJIANG PHARMA
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to solve the problem that there is no Chinese patent medicine with quick effect, good effect and convenient use in the existing treatment of breast diseases, and to provide a Chinese patent medicine for the treatment of breast diseases that adopts an oral mode, is convenient to use, and has a quick effect and its preparation method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese patent medicine for treating breast diseases and preparation method thereof
  • Chinese patent medicine for treating breast diseases and preparation method thereof
  • Chinese patent medicine for treating breast diseases and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0044] A Chinese patent medicine for treating mammary gland diseases, prepared from the following Chinese medicinal materials in parts by weight: 1 part of Bupleurum bupleurum, 3 parts of Saponaria thorn, 3 parts of Wang Buliuxing, 1 part of Prunella vulgaris, 2 parts of Radix Paeoniae Rubra, 3 parts of gold, 2 parts of oysters, 2 parts of salvia miltiorrhiza, 3 parts of orange core, 2 parts of trigonum, 0.5 parts of curcuma, and 0.5 parts of licorice.

[0045] The preparation method of the Chinese patent medicine for the treatment of mammary gland disease described in the present embodiment, comprises the steps:

[0046] Step 1. Take a certain weight of Bupleurum, Curcuma, Salvia, Curcuma, and Sanleng according to the parts by weight, crush the weighed medicinal materials and pass through an 80-mesh sieve for later use;

[0047] Step 2, sterilizing the fine powder of medicinal materials pulverized in step 1 by microwave for subsequent use;

[0048] Step 3. Weigh a certain we...

specific Embodiment approach 2

[0090] The difference between this embodiment and specific embodiment 1 is that this embodiment is prepared from the following Chinese medicinal materials in parts by weight: 3 parts of Bupleurum bupleuri, 4 parts of saponins, 5 parts of blancia, 5 parts of Prunella vulgaris, 4 parts of red peony root, 6 parts of turmeric, 3 parts of oyster, 4 parts of salvia miltiorrhiza, 3 parts of orange core, 3 parts of trigonum, 1 part of curcuma, 1 part of licorice.

[0091] Under the present embodiment, pharmacodynamic experiments are carried out: from the intramuscular injection of estradiol benzoate and progesterone to replicate the disease model of mammary gland hyperplasia in rats and the intraperitoneal injection of estradiol benzoate to replicate the disease model of mouse mammary gland hyperplasia, two aspects of the main drug Efficacy test, to prove that the Chinese patent medicine for the treatment of mammary gland diseases has the effect of inhibiting mammary gland hyperplasia....

specific Embodiment approach 3

[0159]The difference between this embodiment and specific embodiment 1 or 2 is that this embodiment is prepared from the following Chinese medicinal materials in parts by weight: 4 parts of Bupleurum bupleuri, 5 parts of saponins, 6 parts of buliuxin, and 6 parts of Prunella vulgaris 5 parts of red peony root, 5 parts of turmeric, 4 parts of oyster, 5 parts of salvia miltiorrhiza, 4 parts of orange core, 4 parts of trigonum, 2 parts of curcuma, and 1 part of licorice.

[0160] The Chinese patent medicine for the treatment of breast disease prepared in this embodiment, the anti-inflammatory effect research is as follows:

[0161] 1. Test drug:

[0162] Test sample: the Chinese patent medicine for the treatment of breast diseases;

[0163] Positive control: Rujiling, produced by Xi'an Taiji Pharmaceutical Co., Ltd., batch number: 130601.

[0164] 2. Test animals:

[0165] 110 healthy SPF-grade SD female non-pregnant rats, weighing 180±20g, were purchased from Liaoning Changsh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Chinese patent medicine for treating breast diseases and a preparation method thereof and belongs to the field of traditional Chinese medicines. The Chinese patent medicine is prepared from the following traditional Chinese medicinal materials in parts by weight: 1-7 parts of radix bupleuri, 1-6 parts of spina gleditsiae, 1-6 parts of cowherb seeds, 1-8 parts of selfheal, 1-7 parts of a red peony root,1-6 parts of curcuma aromatica, 1-4 parts of oyster, 1-5 parts of salviae miltiorrhizae,1-5 parts of tangerine seeds, 1-5 parts of rhizoma sparganii, 0.3-2 parts of curcuma zedoary and 0.3-2 parts of liquorice. The Chinese patent medicine is capable of treating qi and blood, taking sputum and stasis into account and playing roles in smoothing the liver, regulating qi, promoting blood circulation to arrest pain, reducing phlegm and resolving masses. Therefore, breast lumps can be slowly dispersed to achieve the prefect effect. The Chinese patent medicine is low in cost, convenient to use, fast in acting and significant in effect, and no recurrence after radical cure can be achieved. The Chinese patent medicine has good curative effects on breast lumps, breast pain, hyperplasia of mammary glands and mastitis, and the total effective rate is 93.9%; and through animal experiment result analysis, the Chinese patent medicine is low in toxicity and safe in clinical medication.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a Chinese patent medicine for treating breast diseases and a preparation method thereof. Background technique [0002] Breast disease is a common disease, frequently-occurring disease, and a major disease that endangers women's physical and mental health. Among urban women, breast disease has become the number one enemy. If the treatment is not timely and improper, lesions may occur, and mutations may lead to life-threatening at any time. According to statistics, 70% to 90% of women have breast hyperplasia, and the incidence rate is extremely high. About 1 / 4 to 1 / 3 of women have suffered from breast disease in their lifetime. The incidence rate of urban women is higher than that of rural women, which may be related to cultural knowledge, emphasis on disease and even tolerance. The peak is between 30 and 50 years old, and it is rare after puberty and po...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61K9/48A61P15/14A61K35/618
CPCA61K9/1605A61K35/618A61K36/233A61K36/36A61K36/483A61K36/484A61K36/536A61K36/537A61K36/65A61K36/71A61K36/752A61K36/902A61K36/9066A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 刘艳青李宝谢兴琴沈嘉琪高亚春牛春玮金海英王巍
Owner HEILONGJIANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products